Literature DB >> 2114999

Definition of the human immunoglobulin variable lambda (IGLV) gene subgroups.

P Chuchana1, A Blancher, F Brockly, D Alexandre, G Lefranc, M P Lefranc.   

Abstract

Comparison of 60 human immunoglobulin variable lambda (IGLV) sequences allowed us to define seven subgroups designated V lambda I to V lambda VII. We demonstrate that all lambda proteins sequenced so far fall into the subgroups I, II, III and VI, and that the lambda regions previously assigned to subgroups IV and V belong, in fact, to subgroups III and II, respectively. Four sequences not belonging to any of the subgroups I, II, III and VI define the new subgroups IV, V and VII. Interestingly, these subgroups show a higher homology to rabbit or mouse V lambda genes than to the other human V lambda subgroups. By comparison of the proteins either with the sequences deduced from the germ-line genes or with the consensus sequences, the rate of amino acid changes due to somatic mutations or allelic variations was evaluated in several lambda proteins. Framework and complementarity-determining regions of the human IGLV genes and proteins were delineated. Alignment of the lambda sequences shows that functional V-J rearrangement occurs, with or without deletion of nucleotides encoding one or two amino acids at the 3' end of the V gene. Diversity of the third complementarity-determining region is due to somatic mutations and to flexible V-J junction, but there is no evidence of N-diversity in the human lambda locus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114999     DOI: 10.1002/eji.1830200618

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Nucleotide sequence of the Corynebacterium glutamicum trpE gene.

Authors:  D M Heery; L K Dunican
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

2.  First genomic sequence of a human Ig variable lambda gene belonging to subgroup III.

Authors:  J P Frippiat; P Chuchana; F Bernard; L Buluwela; G Lefranc; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

3.  Genomic sequence of IGLV1S2, a human immunoglobulin variable lambda gene belonging to subgroup I.

Authors:  F Bernard; P Chuchana; J P Frippiat; L Buluwela; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

4.  The IGLVA gene as a STS in the human immunoglobulin lambda light chain variable gene locus (located at 22q11)

Authors:  P Chuchana; D Alexandre; G Lefranc; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

5.  HindIII RFLP of the human immunoglobulin V lambda III subgroup genes.

Authors:  P Chuchana; A Blancher; G Lefranc; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

Review 6.  Structural and functional properties of human lambda-light-chain variable-region subgroups.

Authors:  A Solomon; D T Weiss
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

7.  Characterization of a lymphoblastoid line deleted for lambda immunglobulin genes.

Authors:  C A Hough; B N White; J J Holden
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations.

Authors:  E E Adderson; P G Shackelford; R A Insel; A Quinn; P M Wilson; W L Carroll
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  Expansion of a B-lymphocyte clone producing IgM auto-antibodies encoded by a somatically mutated VHI gene in the spleen of an autoimmune patient.

Authors:  S Jahn; B Niemann; T Winkler; J R Kalden; R von Baehr
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

10.  Molecular analysis of the human immunoglobulin V lambda II gene family.

Authors:  M Irigoyen; A Manheimer-Lory; B Gaynor; B Diamond
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.